Annals
Established in 1927 by the American College of Physicians
:
Advanced search
 
box Article
 arrow  Table of Contents                
space
 arrow  Full Text of this article Free
space
 arrow  Figures/Tables List
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  Hornberger, J.
space
  arrow  Wrone, E.
space
 arrow  Related Articles in PubMed
space
 arrow  PubMed Citation
space
 arrow  PubMed
space

RESEARCH

When To Base Clinical Policies on Observational Versus Randomized Trial Data

right arrow John Hornberger, MD, MS, and Elizabeth Wrone, MD

15 October 1997 | Volume 127 Issue 5 Part 2 | Pages 697-703

Physicians must decide when the evidence is sufficient to adopt a new clinical policy. Analysis of large clinical and administrative databases is becoming an important source of evidence for changing clinical policies. Because such analysis cannot control for the effects of all potential confounding variables, physicians risk drawing the wrong conclusion about the cause-and-effect relation between a change in clinical policy and outcomes. Randomized studies offer protection against drawing a conclusion that would lead to adoption of an inferior policy. However, a randomized study may be difficult to justify because of the extra costs of collecting data for a randomized study and concerns that a study will not directly benefit the patients enrolled in the study. This article reviews the advantages and disadvantages of basing clinical policy on analysis of large databases compared with conducting a randomized study. A technique is described and illustrated for accessing the potential costs and benefits of conducting such a study. This type of analysis formed the basis for a physician-managed health care organization deciding to sponsor a randomized study among patients with end-stage renal disease as part of a quality-improvement initiative.

Author and Article Information
space

From the Stanford University School of Medicine, Stanford, California.
Note: This article is one of a series of articles comprising an Annals of Internal Medicine supplement entitled "Measuring Quality, Outcomes, and Cost of Care Using Large Databases: The Sixth Regenstrief Conference." To see a complete list of the articles included in this supplement, please view its Table of Contents.
Acknowledgments: The authors thank Siu Hui, Linda McCann, Philip Lavori, Mary Anne Rodgers, and two anonymous referees for their comments on the manuscript.
Requests for Reprints: John Hornberger, MD, MS, Department of Health Research and Policy, Stanford University School of Medicine, HAP Redwood Building, Room T254A, Stanford, CA 94305-5092.
Current Author Addresses: Dr. Hornberger: Department of Health Research and Policy, Stanford University School of Medicine, HAP Redwood Building, Room T254A, Stanford, CA 94305-5092.







 Home | Current Issue | Past Issues | In the Clinic | ACP Journal Club | CME | Collections | Audio/Video | Mobile | Subscribe | Tools | Help | ACP Online 

Copyright © 1997 by the American College of Physicians.